Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Genetic Technologies Limited, often referred to as GeneType, is a pioneering biotechnology company headquartered in Australia. Founded in 2000, the company has established itself as a leader in the field of genetic testing and personalised medicine, with a focus on providing innovative solutions for health management and disease prevention.
Operating primarily in Australia and expanding into international markets, Genetic Technologies offers a range of unique genetic testing services. Their flagship product, the GeneType test, empowers individuals with insights into their genetic predispositions, enabling informed health decisions. The company is recognised for its commitment to advancing genetic research and has achieved significant milestones in the development of non-invasive testing methods.
With a strong market position, Genetic Technologies Limited continues to drive innovation in the biotechnology sector, contributing to the growing demand for personalised healthcare solutions.
-24 vs industry average
Genetic Technologies Limited’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Genetic Technologies Limited yet.
Genetic Technologies Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Genetic Technologies Limited may not have established a comprehensive framework for addressing its carbon footprint or climate impact at this time. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate commitments to align with global standards and expectations.
No climate goals have been disclosed for Genetic Technologies Limited yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more